0001209191-18-062108.txt : 20181211
0001209191-18-062108.hdr.sgml : 20181211
20181211193747
ACCESSION NUMBER: 0001209191-18-062108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181207
FILED AS OF DATE: 20181211
DATE AS OF CHANGE: 20181211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FISHER MARY
CENTRAL INDEX KEY: 0001272360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 181229840
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 15 SKYLINE DRIVE
CITY: HAWTHORNE
STATE: NY
ZIP: 10532
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-07
1
0001544227
Millendo Therapeutics, Inc.
MLND
0001272360
FISHER MARY
C/O MILLENDO THERAPEUTICS, INC.
301 N. MAIN ST., SUITE 100
ANN ARBOR
MI
48104
1
0
0
0
Common Stock
2018-12-07
4
A
0
355
0.00
A
3319
D
The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.
Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
/s/ Jonathan Gillis, Attorney-in-Fact
2018-12-11